AD

(2R,3R,4S,5R,6R)-2-[(2S,3R,4S,5S)-4-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-[[(1S,2R,5R,7S,10R,11R,14R,15S,16S,18R,20S)-16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-enyl)-19,21-dioxahexacyclo[18.2.1.01,14.02,11.05,10.015,20]tricosan-7-yl]oxy]oxan-3-yl]oxy-6-methyloxane-3,4,5-triol(CAS: 68144-21-8)

(2R,3R,4S,5R,6R)-2-[(2S,3R,4S,5S)-4-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-[[(1S,2R,5R,7S,10R,11R,14R,15S,16S,18R,20S)-16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-enyl)-19,21-dioxahexacyclo[18.2.1.01,14.02,11.05,10.015,20]tricosan-7-yl]oxy]oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
CAS Number

Related Products

Other Suppliers for (2R,3R,4S,5R,6R)-2-[(2S,3R,4S,5S)-4-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-[[(1S,2R,5R,7S,10R,11R,14R,15S,16S,18R,20S)-16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-enyl)-19,21-dioxahexacyclo[18.2.1.01,14.02,11.05,10.015,20]tricosan-7-yl]oxy]oxan-3-yl]oxy-6-methyloxane-3,4,5-triol

Basic Information

Molecular Formula
C52H84O21
Molecular Weight
1045.2 g/mol
Physical State
Powder

Physical Properties

Density
1.44

Chemical Identifiers

SMILES
CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC6C7C(CC(OC78CC6(C5(CCC4C3(C)C)C)CO8)C=C(C)C)(C)O)C)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(CO1)O)O)O)O)O)O
InChIKey
OAVAUZCEOWCYCC-JHTONXGASA-N

Database References

MDL Number
MFCD28009139

FAQ

This compound falls under the purview of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous substances. It is also regulated under the European Union's REACH (Registration, Evaluation, Authorisation, and Restriction of Chemicals) regulations, as well as FDA and EPA guidelines. Specific safety and handling guidelines must be adhered to, including proper storage, transport, and disposal, to ensure worker safety and environmental protection.
While specific alternatives may not be readily available, researchers often explore structural analogs and isomers as alternatives. Commonly, substitute reagents like diols, amino acids, or other cyclic ethers can be used depending on the specific synthetic pathway. It is crucial to evaluate the structural and functional properties of these alternatives to ensure they meet the desired requirements for the application.
Research in this area is currently focused on understanding the biological activity and potential therapeutic applications of this compound. Market trends suggest an increasing interest in its use as a precursor or intermediate in the synthesis of more complex natural products and pharmaceuticals. Price trends indicate that due to its complex structure and limited availability, the compound is relatively expensive. However, ongoing research could lead to more efficient synthesis methods and cost reductions.
Waste containing this compound should be collected in appropriate containers and stored in a well-ventilated area. For incineration, professional waste disposal services should be utilized to ensure compliance with environmental regulations. Safe handling procedures include wearing personal protective equipment (PPE) and following local, regional, and national disposal guidelines to prevent environmental contamination and ensure worker safety.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Email

xxiang08@126.com